“Effective, rapid, low-cost diagnostic tools are needed for guiding optimal use of antibiotics in human and animal medicine, and such tools should be easily integrated into clinical, pharmacy and veterinary practices. Evidence-based prescribing and dispensing should be the standard of care.”

– WHO Global action plan on antimicrobial resistance

Astrego Diagnostics develops rapid diagnostic tools that enable evidence-based antibiotic treatments.

Technology

Astrego’s disruptive technology makes it possible to capture individual bacterial cells from complex samples and measure their growth rate in real-time. This enables the fastest possible Antibiotic Susceptibility Test (AST).

Applications

Products targeting a wide range of microbiological applications, designed to enable evidence-based prescription of antibiotics and help reduce the spread of antimicrobial resistance (AMR).

The Company

Astrego Diagnostics is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. Our team combines multidisciplinary scientific excellence with seasoned diagnostic industry management.

This website use cookies.
By using the website you consent to this.
Read more here.